AI.NYSEC3ai, INC

Form 4: Condoleezza Rice Acquires Stock Options in C3.ai, Inc.

Sentiment:

SEC Form 4 Filing


Condoleezza Rice, a director of C3.ai, Inc., was granted stock options to purchase 23,642 shares of Class A Common Stock on October 2, 2024.

Summary

  • On October 2, 2024, Condoleezza Rice, a director of C3.ai, Inc., acquired stock options for 23,642 shares of Class A Common Stock.
  • The exercise price of the stock options is $22.89.
  • The options vest quarterly, with 5% of the shares vesting on the last day of each fiscal quarter, contingent upon Ms. Rice's attendance at regularly scheduled board meetings.
  • If Ms. Rice fails to attend a meeting, the vesting of those shares will be suspended and may vest after the fifth anniversary of the Vesting Commencement Date if attendance requirements are met in subsequent periods.
  • The options expire on October 1, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard transaction (stock option grant) and doesn't contain any alarming or negative information. The vesting schedule incentivizes continued service, which is generally viewed positively.

Positives

  • The grant of stock options to a director aligns her interests with those of the shareholders.
  • The vesting schedule incentivizes continued engagement and attendance at board meetings.

Risks

  • The vesting schedule is contingent on attendance at board meetings, which could be affected by unforeseen circumstances.
  • Suspended shares may not vest until the fifth anniversary of the Vesting Commencement Date, potentially delaying the director's ability to benefit from the options.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.

Industry Context

Stock option grants are a common form of compensation for directors and executives in publicly traded companies, aligning their interests with those of shareholders and incentivizing long-term value creation.

Comparison to Industry Standards

  • Stock option grants to board members are a common practice across the tech industry, with vesting schedules typically tied to continued service.
  • The specific terms of the grant, such as the exercise price and vesting schedule, are generally determined by the company's compensation committee and are benchmarked against peer companies to ensure competitiveness.

Stakeholder Impact

  • Shareholders may view the stock option grant positively as it aligns the director's interests with the company's long-term success.
  • The vesting schedule incentivizes the director's continued engagement and contribution to the company.

Key Dates

DateDescription
10/02/2024Date of the transaction (grant of stock options)
10/02/2024Vesting Commencement Date
10/01/2034Expiration date of the stock options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.